Skip to Content
Merck
  • p38α MAPK proximity assay reveals a regulatory mechanism of alternative splicing in cardiomyocytes.

p38α MAPK proximity assay reveals a regulatory mechanism of alternative splicing in cardiomyocytes.

Biochimica et biophysica acta. Molecular cell research (2019-09-11)
Audrey-Ann Dumont, Lauralyne Dumont, Jonathan Berthiaume, Mannix Auger-Messier
ABSTRACT

The p38 mitogen-activated protein kinase (MAPK) signaling pathway is essential for normal heart function. However, p38 also contributes to heart failure pathogenesis by affecting cardiomyocytes contractility and survival. To unravel part of the complex role of p38 in cardiac function, we performed an APEX2-based proximity assay in cultured neonatal rat ventricular myocytes and identified the protein interaction networks (interactomes) of two highly expressed p38 isoforms in the heart. We found that p38α and p38γ have distinct interactomes in cardiomyocytes under both basal and osmotic stress-activated states. Interestingly, the activated p38α interactome contains many RNA-binding proteins implicated in splicing, including the serine/arginine-rich splicing factor 3 (SRSF3). Its interaction with the activated p38α was validated by co-immunoprecipitation. The cytoplasmic abundance and alternative splicing function of SRSF3 are also both modulated by the p38 signaling pathway. Our findings reveal a new function for p38 as a specific regulator of SRSF3 in cardiomyocytes.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
MAPKAPK2 human, recombinant, expressed in HEK 293 cells, ≥60 units/mg protein, buffered aqueous glycerol solution
Sigma-Aldrich
Monoclonal ANTI-FLAG® M2 antibody produced in mouse, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)